Publication
Targeting RAS for Pancreatic Cancer Interception.
Sandra Misale, Neeha Zaidi, Elizabeth M Jaffee, Alison P Klein, Laura D Wood
Cancer discoverySep 22, 2026PMID 42770704doi:10.1158/2159-8290.CD-26-1179 Journal ArticlepubmedProvenance
- Source
- PubMed
- Retrieved
- Sep 28, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-PUBMED-20260928-000001
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
Multiple strategies to target RAS are now available to treat pancreatic cancer. As pancreatic precancers also have KRAS mutations, these tools hold great promise for cancer interception.
Read on PubMedLinked entities
Linked entities (1)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Candidate 1
- cancerMalignant Pancreatic Neoplasmdictionary0.60
Curated evidence
Evidence citing this paper (0)
Data not yet available
No curated evidence item cites this publication.